ComASP Oritavancin is a ready to use panel to establish the minimum inhibitory concentrations (MICs) of Oritavancin (0.001 – 16 μg/ml).
The system is used to perform the broth microdilution (BMD) method for the antimicrobial susceptibility testing of Oritavancin as recommended by international standards (i.e. CLSI, EUCAST, ISO)
The ComASP range includes